In vitro and in vivo antibacterial activities of CS-834, a new oral carbapenem

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 3, 1998, Pages 555-563

  Yamaguchi, Keizo ^a   Domon, Haruki ^a   Miyazaki, Shuichi ^a   Tateda, Kazuhiro ^a   Ohno, Akira ^a   Ishii, Kazuhiro ^a   Matsumoto, Tetsuya ^a   Furuya, Nobuhiko ^a  

^a TOHO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

6 (1 HYDROXYETHYL) 4 METHYL 7 OXO 3 (5 OXO 3 PYRROLIDINYLTHIO) 1 AZABICYCLO[3.2.0]HEPT 2 ENE 2 CARBOXYLIC ACID; 6 (1 HYDROXYETHYL) 4 METHYL 7 OXO 3 (5 OXO 3 PYRROLIDINYLTHIO) 1 AZABICYCLO[3.2.0]HEPT 2 ENE 2 CARBOXYLIC ACID PIVALOYLOXYMETHYL ESTER; AMOXICILLIN; CARBAPENEM; CEFDINIR; CEFDITOREN PIVOXIL; CEFPODOXIME PROXETIL; IMIPENEM; METICILLIN; OFLOXACIN; PENICILLIN G; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PENICILLIN RESISTANCE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION;

EID: 0031894494     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.3.555     Document Type: Article

References (17)

1. Asahi, Y., S. Miyazaki, and K. Yamaguchi. 1995. In vitro and in vivo antibacterial activities of BO-2727, a new carbapenem. Antimicrob. Agents Chemother. 39:1030-1037.
2. Bennett, I., N. Broom, K. Coleman, S. Coulton, P. Edwards, I. Fracois, D. Griffin, N. Osborne, and P. Woodall. 1991. 6-(Substituted methylene) penems, potent broad spectrum inhibitors of bacterial beta-lactamase. IV. Kidney stability, serum binding and additional biological evaluation of racemic derivatives. J. Antibiot. 44:338-343.
3. Fantin, B., J. Leggett, S. Ebert, and W. Craig. 1991. Correlation between in vitro and in vivo activity of antimicrobial agents against gram-negative bacilli in a murine infection model. Antimicrob. Agents Chcmother. 35:1413-1422.
4. Fukasawa, M., Y. Sumita, E. T. Harabe, T. Tanino, H. Nouda, T. Kohzuki, T. Okuda, H. Matsumura, and M. Sunagawa. 1992. Stability of meropenem and effect of 1β-methyl substitution on its stability in the presence of renal dehydropeptidase I. Antimicrob. Agents Chemother. 36:1577-1579.
5. Gnarpe, H., J. Belsheim, C. Blomqvist, and A. Lundback. 1984. Stimulation of granulocyte functions in vitro by imipenem and the renal enzyme inhibitor MK 0791. Antimicrob. Agents Chemother. 25:178-181.
6. Hikida, M., K. Kawashima, M. Yoshida, and S. Mitsuhashi. 1992. Inactivation of new carbapenem antibiotics by dehydropeptidase-I from porcine and human renal cortex. J. Antimicrob. Chemother. 30:129-134.
7. Ishii, Y., A. Ohno, H. Taguchi, S. Imajo, M. Ishiguro, and H. Matsuzawa. 1995. Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A beta-lactamase isolated from Escherichia coli. Antimicrob. Agents Chemother. 39:2269-2275.
8. Jacobs, C., L. Huang, E. Bartowsky, S. Normark, and J. Park. 1994. Bacterial cell wall recycling provides cytosolic muropeptides as effectors for beta-lactamase induction. EMBO J. 13:4684-4694.
9. Japanese Society for Chemotherapy. 1990. Method for the determination of minimum inhibitory concentration (MIC) of aerobic bacteria by microdilution method. Chemotherapy (Tokyo) 38:102-105.
10. Japanese Society for Chemotherapy. 1993. Method for the determination of minimum inhibitory concentration (MIC) of fastidious bacteria and anaerobic bacteria by microdilution method. Chemotherapy (Tokyo) 41:183-189.
11. Miyauchi, M., R. Endo, M. Hisaoka, H. Yasuda, and I. Kawamoto. 1997. Synthesis and structure-activity relationships of a novel oral carbapenem, CS-834, J. Antibiot. 50:429-439.
12. Miyazaki, S., T. Nunoya, T. Matsumoto, K. Tateda, and K. Yamaguchi. 1997. New murine model o'f bronchopneumonia due to cell-bound Haemophilus influence. J. Infect. Dis. 175:205-209.
13. Nakashima, M., K. Umemura, Y. Ikeda, and K. Kondou. 1996. CS-834, a new oral carbapenem V. Safety and pharmacokinetics in healthy male volunteer, abstr. F109, p. 119. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
14. Sanders, C. 1987. Chromosomal cephalosporinases responsible for multiple resistance to newer beta-lactam antibiotics. Annu. Rev. Microbiol. 41:573-593.
15. Shimada, J., and Y. Kawahara. 1994. Overview of a new carbapenem, panipenem/betamipron. Drags Exp. Clin. Res. 20:241-245.
16. Takashima, K., K. Tateda, T. Matsumoto, T. Ito, Y. Iizawa, M. Nakao, and K. Yamaguchi. 1996. Establishment of a model of penicillin-resistant Streptococcus pneumoniae pneumonia in healthy CBA/J mice. J. Med. Microbiol. 45:319-322.
17. Tsuji, A., H. Sato, I. Tamai, H. Adachi, T. Nishihara, M. Ishiguro, N. Ohmura, and T. Noguchi. 1990. Physiologically based pharmacokinetics of a new penem, SUN5555, for evaluation of in vivo efficacy. Drug Metab. Dispos. 18:245-252.